Marker Therapeutics, Inc.
MRKR · XNASCIK 1094038fmd_0D5T0TG8PW8ANHAKNN8BSRWMRVManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2000 to Jun 30, 2026, 76 periods
News summary
An AI model writes the summary on request, from this company's recent filings only, and cites each filing it uses.
AI-written
0 filings
From 8-K filings, not wire news: the items each filer selected on the EDGAR cover, grouped by event type. Importance is FinancialMD's own rule by item number (5: bankruptcy, non-reliance, change of control, delisting, cybersecurity; 1: exhibits only).
Loading